These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 32839427)
1. NEDDylation negatively regulates ERRβ expression to promote breast cancer tumorigenesis and progression. Naik SK; Lam EW; Parija M; Prakash S; Jiramongkol Y; Adhya AK; Parida DK; Mishra SK Cell Death Dis; 2020 Aug; 11(8):703. PubMed ID: 32839427 [TBL] [Abstract][Full Text] [Related]
2. Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity. Jia X; Li C; Li L; Liu X; Zhou L; Zhang W; Ni S; Lu Y; Chen L; Jeong LS; Yu J; Zhang Y; Zhang J; He S; Hu X; Sun H; Yu K; Liu G; Zhao H; Zhang Y; Jia L; Shao ZM Clin Cancer Res; 2019 Jun; 25(12):3658-3672. PubMed ID: 30833270 [TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer. Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638 [TBL] [Abstract][Full Text] [Related]
4. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer. Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947 [TBL] [Abstract][Full Text] [Related]
5. ERRβ signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells. Sengupta D; Bhargava DK; Dixit A; Sahoo BS; Biswas S; Biswas G; Mishra SK Br J Cancer; 2014 Apr; 110(8):2144-58. PubMed ID: 24667650 [TBL] [Abstract][Full Text] [Related]
6. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway. Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638 [TBL] [Abstract][Full Text] [Related]
7. Overactivated neddylation pathway as a therapeutic target in lung cancer. Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380 [TBL] [Abstract][Full Text] [Related]
8. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells. Lan H; Tang Z; Jin H; Sun Y Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292 [TBL] [Abstract][Full Text] [Related]
9. Estrogen-related Receptor β Reduces the Subnuclear Mobility of Estrogen Receptor α and Suppresses Estrogen-dependent Cellular Function. Tanida T; Matsuda KI; Yamada S; Hashimoto T; Kawata M J Biol Chem; 2015 May; 290(19):12332-45. PubMed ID: 25805499 [TBL] [Abstract][Full Text] [Related]
10. Abnormal Cullin1 neddylation-mediated p21 accumulation participates in the pathogenesis of recurrent spontaneous abortion by regulating trophoblast cell proliferation and differentiation. Sun X; Tong X; Hao Y; Li C; Zhang Y; Pan Y; Dai Y; Liu L; Zhang T; Zhang S Mol Hum Reprod; 2020 May; 26(5):327-339. PubMed ID: 32186736 [TBL] [Abstract][Full Text] [Related]
11. MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma. Tong S; Si Y; Yu H; Zhang L; Xie P; Jiang W Sci Rep; 2017 Jul; 7(1):5599. PubMed ID: 28717191 [TBL] [Abstract][Full Text] [Related]
12. The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme. Yang D; Tan M; Wang G; Sun Y PLoS One; 2012; 7(3):e34079. PubMed ID: 22457814 [TBL] [Abstract][Full Text] [Related]
13. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells. Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162 [TBL] [Abstract][Full Text] [Related]
14. Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer. Yu S; Wong YC; Wang XH; Ling MT; Ng CF; Chen S; Chan FL Oncogene; 2008 May; 27(23):3313-28. PubMed ID: 18071305 [TBL] [Abstract][Full Text] [Related]
15. CBS9106-induced CRM1 degradation is mediated by cullin ring ligase activity and the neddylation pathway. Saito N; Sakakibara K; Sato T; Friedman JM; Kufe DW; VonHoff DD; Kawabe T Mol Cancer Ther; 2014 Dec; 13(12):3013-23. PubMed ID: 25253782 [TBL] [Abstract][Full Text] [Related]
16. MLN4924 inhibits cell proliferation by targeting the activated neddylation pathway in endometrial carcinoma. Liu H; Bei Q; Luo X J Int Med Res; 2021 Jun; 49(6):3000605211018592. PubMed ID: 34082605 [TBL] [Abstract][Full Text] [Related]
17. UBC12-mediated SREBP-1 neddylation worsens metastatic tumor prognosis. Heo MJ; Kang SH; Kim YS; Lee JM; Yu J; Kim HR; Lim H; Kim KM; Jung J; Jeong LS; Moon A; Kim SG Int J Cancer; 2020 Nov; 147(9):2550-2563. PubMed ID: 32449166 [TBL] [Abstract][Full Text] [Related]
18. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells. Fan M; Bigsby RM; Nephew KP Mol Endocrinol; 2003 Mar; 17(3):356-65. PubMed ID: 12554766 [TBL] [Abstract][Full Text] [Related]
19. Stabilization of HIF through inhibition of Cullin-2 neddylation is protective in mucosal inflammatory responses. Curtis VF; Ehrentraut SF; Campbell EL; Glover LE; Bayless A; Kelly CJ; Kominsky DJ; Colgan SP FASEB J; 2015 Jan; 29(1):208-15. PubMed ID: 25326537 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib. Yang Z; Zhang J; Lin X; Wu D; Li G; Zhong C; Fang L; Jiang P; Yin L; Zhang L; Bie P; Xie CM Oncol Rep; 2019 Jun; 41(6):3257-3269. PubMed ID: 31002342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]